|
Q-Line Biotech Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
1074.61 Cr.
|
P/BV
|
4.55
|
Book Value (Rs.)
|
101.26
|
|
52 Week High/Low (Rs.)
|
483/431
|
FV/ML
|
10/400
|
P/E(X)
|
38.20
|
|
Bookclosure
|
|
EPS (Rs.)
|
12.06
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 44.19 | 30.61 | 29.84 |
| | | | |
| Net CashFlow From Operating Activities | -1.32 | -24.18 | 24.97 |
| Net Cash Used In Investing Activities | -59.09 | -44.69 | -26.31 |
| Net Cash Used From Financing Activities | 53.34 | 16.99 | 26.40 |
| | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -7.07 | -51.88 | 25.06 |
| Cash And Cash Equivalents Begin of Year | 19.71 | 71.60 | 46.54 |
| Cash And Cash Equivalents End Of Year | 12.64 | 19.71 | 71.60 |